Inventor · disambiguated record
Antony Rosen
Also filed as: ROSEN ANTONY
9 granted patents·12 pending applications·3 citations·filing 2004–2024
79Inventor score
Top patents by PatentIndex Score
21 records- 0174US2024342277A1Autoimmune antibodies for use in inhibiting cancer cell growthUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 0267US8778618B2Compositions and methods for characterizing a myopathyCASCIOLA-ROSEN LIVIA ANGELA·Filed 2011·Granted Jul 15, 2014·2 cites·20 claims
- 0366US11938183B2Autoimmune antibodies for use in inhibiting cancer cell growthUNIV JOHNS HOPKINS·Filed 2021·Granted Mar 26, 2024·0 cites·17 claims
- 0465US9417247B2Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseasesUNIV JOHNS HOPKINS·Filed 2015·Granted Aug 16, 2016·1 cites·9 claims
- 0565US2023104322A1Methods for identifying patterns of ifn induced expression and use in diagnosis, monitoring and therapyUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 0664US10874726B2Autoimmune antigens and cancerUNIV JOHNS HOPKINS·Filed 2014·Granted Dec 29, 2020·0 cites·15 claims
- 0759US11454630B2Materials and methods for assessing cancer risk and treating cancerUNIV JOHNS HOPKINS·Filed 2018·Granted Sep 27, 2022·0 cites·4 claims
- 0859US11366113B2Methods for identifying patterns of IFN induced expression and use in diagnosis, monitoring and therapyUNIV JOHNS HOPKINS·Filed 2018·Granted Jun 21, 2022·0 cites·9 claims
- 0958US9506924B2Compositions and methods for characterizing a myopathyUNIV JOHNS HOPKINS·Filed 2016·Granted Nov 29, 2016·0 cites·18 claims
- 1058US9335326B2Compositions and methods for characterizing a myopathyUNIV JOHNS HOPKINS·Filed 2014·Granted May 10, 2016·0 cites·21 claims
- 1156US2021100882A1Autoimmune antigens and cancerUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1256US2024302367A1Methods and materials for treating cancerUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1353US2024069023A1DETECTION OF ACE2 IgM AUTOANTIBODIES AS MARKERS OF SEVERITY AND MECHANISM IN COVID19 PATIENTSUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1452US2024241118A1Autoantibodies for use in identifying diseaseUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1552US2014287951A1Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune DiseasesUNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 1651US8975033B2Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseasesUNIV JOHNS HOPKINS·Filed 2013·Granted Mar 10, 2015·0 cites·24 claims
- 1751US2005112137A1Autoantigenic fragments, methods and assaysFiled 2004·Application pending·0 cites
- 1850US2015168398A1Methods for identifying patterns of ifn induced expression and use in diagnosis, monitoring and therapyUNIV JOHNS HOPKINS·Filed 2013·Application pending·0 cites
- 1946US2018104331A1Autoimmune antibodies for use in inhibiting cancer cell growthUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
- 2040US2012190581A1Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune DiseasesBOCHNER BRUCE SCOTT·Filed 2010·Application pending·0 cites
- 2134US2013101611A1Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicityANDRADE FELIPE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antony Rosen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →